Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Voyager Therapeutics, Inc. (NASDAQ: VYGR)
VYGR Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
26.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
VYGR Stock Analysis
VYGR
PE Ratio:
VYGR
PEG Ratio:
Not Available
VYGR
Forward EPS Growth (12 month):
0.00%
VYGR
PS Ratio:
6
VYGR
PSG Ratio:
0.2
VYGR
Forward Revenue Growth (12 month):
33.30%
VYGR Articles
No data was found